HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA Packages Suggestions To Amend DSHEA In Fiscal Year 2023 Budget Request

Executive Summary

Biden administration’s FY2023 budget request for FDA includes $1.23bn for food programs, which include regulation of supplement manufacturing and marketing. The funding, an increase of more than $128,000 from FDA’s current food programs budget, would be split between $419,932 for CFSAN and $800,261 for related field work by ORA.

You may also be interested in...



House Appropriators Reject Docking FDA FY2023 Budget Until Formula Crisis Report Provided

First-term Iowa Republican Hinson had support from Democrat as well as other GOP members for withholding part of commissioner office’s FY2023 budget. Opposition from a self-acknowledged unlikely source, committee chair DeLauro, steered votes toward rejecting the proposal.

House Has Slim Boost For FDA FY2023 Spending, But Wants Slimmer Budget Document From Agency

Appropriations Committee publishes FY2023 spending bill and report FDA day before it votes on the legislation. It recommends increasing FDA’s budget by less than $400m from its current appropriation to $6.48bn.

No Longer Draft, Senate Mandatory Supplement Registration Bill Gets Flood Of Opposition

Some stakeholders have supported mandatory listing but they join opponents questioning legislation also authorizing FDA to prohibit sales of products compliant with manufacturing and labeling regulations but deficient, incomplete or late with registration information required for the agency.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

RS152353

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel